Lass-Flörl, Cornelia http://orcid.org/0000-0002-2946-7785
Kanj, Souha S. http://orcid.org/0000-0001-6413-3396
Govender, Nelesh P.
Thompson, George R. III
Ostrosky- Zeichner, Luis http://orcid.org/0000-0002-4784-7589
Govrins, Miriam Alisa http://orcid.org/0000-0002-7441-4383
Article History
Accepted: 15 February 2024
First Online: 21 March 2024
Competing interests
: C.L.-F. has received institutional grants from Gilead Sciences and Astellas Pharma, personal consulting fees from Gilead Sciences and Merck Sharp and Dohme, and payments or honoraria for lectures/presentations from Gilead Sciences, Merck Sharp and Dohme, Pfizer, BioMerieux, F2G, Immy and Shionogi. S.S.K. reports honoraria as speaker and for participating in advisory boards for Pfizer, MSD, Basilea, Gilead and Hikma. G.R.T. reports consulting and research support from Astellas, Cidara, F2G, Mundipharma, Melinta, Mayne and Scynexis. L.O.-Z. has received institutional research grants and/or personal consulting honoraria from Merck, Astellas, Pfizer, Cidara, Melinta, Gilead, Scynexis, GSK, Octapharma, Pulmocide, F2G and Eurofins Viracor. M.A.G. and N.P.G. declare no competing interests.